Utilization of and Adherence to Guideline-Recommended Lipid-Lowering Therapy After Acute Coronary Syndrome: Opportunities for Improvement

Journal of the American College of Cardiology

Volumn 66, Issue 2, 2015, Pages 184-192

  Hirsh, Benjamin J ^a   Smilowitz, Nathaniel R ^b   Rosenson, Robert S ^a   Fuster, Valentin ^a   Sperling, Laurence S ^c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

adherence; ezetimibe; low density lipoprotein cholesterol; secondary prevention; statin therapy

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ACUTE CORONARY SYNDROME; ADVERSE OUTCOME; ARTICLE; CARDIOVASCULAR RISK; COMORBIDITY; DRUG EFFICACY; DRUG WITHDRAWAL; HEALTH CARE POLICY; HEALTH LITERACY; HEART PROTECTION; HUMAN; LIFESTYLE; MEDICATION COMPLIANCE; MYALGIA; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SECONDARY PREVENTION; TREATMENT OUTCOME; TREATMENT REFUSAL; CARDIOVASCULAR DISEASES; COMPLICATION; DRUG COMBINATION; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOCIOECONOMICS;

ACUTE CORONARY SYNDROME; CARDIOVASCULAR DISEASES; COMORBIDITY; DRUG THERAPY, COMBINATION; GUIDELINE ADHERENCE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIFE STYLE; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOCIOECONOMIC FACTORS;

EID: 84942417740     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.05.030     Document Type: Review

References (61)

1. A. Tawakol, Z.A. Fayad, R. Mogg, and et al. Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study J Am Coll Cardiol 62 2013 909 917
2. R. Puri, P. Libby, S.E. Nissen, and et al. Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN Eur Heart J Cardiovasc Imaging 15 2014 380 388
3. K.H. Lee, M.H. Jeong, H.M. Kim, and et al. Benefit of early statin therapy in patients with acute myocardial infarction who have extremely low low-density lipoprotein cholesterol J Am Coll Cardiol 58 2011 1664 1671
4. R. Berent, T. Berent, E. Karkutli, and et al. Influence of high-dose highly efficient statins on short-term mortality in patients undergoing percutaneous coronary intervention with stenting for acute coronary syndromes Am J Cardiol 114 2014 1128 1129
5. N.J. Stone, J.G. Robinson, A.H. Lichtenstein, and et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 63 2014 2889 2934
6. C.P. Cannon, M.A. Blazing, R.P. Giugliano, et al. for the IMPROVE-IT Investigators Ezetimibe added to statin therapy after acute coronary syndromes N Engl J Med 372 2015 2387 2397
7. E.P. Navarese, M. Kowalewski, F. Andreotti, and et al. Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention Am J Cardiol 113 2014 1753 1764
8. T.M. Maddox, W.B. Borden, F. Tang, and et al. Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry J Am Coll Cardiol 64 2014 2183 2192
9. N.S. Shah, M.D. Huffman, H. Ning, and et al. Trends in myocardial infarction secondary prevention: The National Health and Nutrition Examination Surveys (NHANES), 1999-2012 J Am Heart Assoc 4 2015 e001709
10. R.S. Rosenson, S.T. Kent, T.M. Brown, and et al. Underutilization of high-intensity statin therapy after hospitalization for coronary heart disease J Am Coll Cardiol 65 2015 270 277
11. S.V. Arnold, J.A. Spertus, F.A. Masoudi, and et al. Beyond medication prescription as performance measures: optimal secondary prevention medication dosing after acute myocardial infarction J Am Coll Cardiol 62 2013 1791 1801
12. S.V. Arnold, M. Kosiborod, F. Tang, and et al. Patterns of statin initiation, intensification, and maximization among patients hospitalized with an acute myocardial infarction Circulation 129 2014 1303 1309
13. U. Javed, P.C. Deedwania, D.L. Bhatt, and et al. Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: an analysis of 65,396 hospitalizations from 344 hospitals participating in Get With The Guidelines (GWTG) Am Heart J 161 2011 418 424.e1-3
14. C.P. Cannon, E. Braunwald, C.H. McCabe, et al. for the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 2004 1495 1504
15. N.J. Leeper, R. Ardehali, E.M. deGoma, and et al. Statin use in patients with extremely low low-density lipoprotein levels is associated with improved survival Circulation 116 2007 613 618
16. T.R. Fried, M.E. Tinetti, and L. Iannone Primary care clinicians' experiences with treatment decision making for older persons with multiple conditions Arch Intern Med 171 2011 75 80
17. R.J. Shaw, J.R. McDuffie, C.C. Hendrix, and et al. Effects of nurse-managed protocols in the outpatient management of adults with chronic conditions: a systematic review and meta-analysis Ann Intern Med 161 2014 113 121
18. P.S. Chan, W.J. Oetgen, D. Buchanan, and et al. Cardiac performance measure compliance in outpatients: the American College of Cardiology and National Cardiovascular Data Registry's PINNACLE (Practice Innovation And Clinical Excellence) program J Am Coll Cardiol 56 2010 8 14
19. J.A. de Lemos, M.A. Blazing, S.D. Wiviott, et al. for the A to Z Investigators Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial JAMA 292 2004 1307 1316
20. G. Sanz, and V. Fuster Prevention: polypills for cardiovascular prevention: a step forward? Nat Rev Cardiol 10 2013 683 684
21. J.N. Rasmussen, A. Chong, and D.A. Alter Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction JAMA 297 2007 177 186
22. J.C. Lauffenburger, J.G. Robinson, C. Oramasionwu, and et al. Racial/ethnic and gender gaps in the use of and adherence to evidence-based preventive therapies among elderly Medicare part D beneficiaries after acute myocardial infarction Circulation 129 2014 754 763
23. P. Muntner, H. Yun, P. Sharma, and et al. Ability of low antihypertensive medication adherence to predict statin discontinuation and low statin adherence in patients initiating treatment after a coronary event Am J Cardiol 114 2014 826 831
24. P.M. Ho, C.L. Bryson, and J.S. Rumsfeld Medication adherence: its importance in cardiovascular outcomes Circulation 119 2009 3028 3035
25. L. Osterberg, and T. Blaschke Adherence to medication N Engl J Med 353 2005 487 497
26. D.M. Cutler, and W. Everett Thinking outside the pillbox - medication adherence as a priority for health care reform N Engl J Med 362 2010 1553 1555
27. A.J. Zimolzak, C.M. Spettell, J. Fernandes, and et al. Early detection of poor adherers to statins: applying individualized surveillance to pay for performance PLoS One 8 2013 e79611
28. S. Sutton, A.L. Kinmonth, W. Hardeman, and et al. Does electronic monitoring influence adherence to medication? Randomized controlled trial of measurement reactivity Ann Behav Med 48 2014 293 299
29. K.D. Checchi, K.F. Huybrechts, J. Avorn, and et al. Electronic medication packaging devices and medication adherence: a systematic review JAMA 312 2014 1237 1247
30. S. Brinker, A. Pandey, C. Ayers, and et al. Therapeutic drug monitoring facilitates blood pressure control in resistant hypertension J Am Coll Cardiol 63 2014 834 835
31. D.M. Mann, N.L. Glazer, M. Winter, and et al. A pilot study identifying statin nonadherence with visit-to-visit variability of low-density lipoprotein cholesterol Am J Cardiol 111 2013 1437 1442
32. P.M. Ho, D.J. Magid, S.M. Shetterly, and et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease Am Heart J 155 2008 772 779
33. M.Y. Wei, M.K. Ito, J.D. Cohen, and et al. Predictors of statin adherence, switching, and discontinuation in the USAGE survey: understanding the use of statins in America and gaps in patient education J Clin Lipidol 7 2013 472 483
34. N.K. Choudhry, M.A. Fischer, J.L. Avorn, and et al. The impact of reducing cardiovascular medication copayments on health spending and resource utilization J Am Coll Cardiol 60 2012 1817 1824
35. J.J. Gagne, N.K. Choudhry, A.S. Kesselheim, and et al. Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study Ann Intern Med 161 2014 400 407
36. L. Vawter, X. Tong, M. Gemilyan, and et al. Barriers to antihypertensive medication adherence among adults-United States, 2005 J Clin Hypertens (Greenwich) 10 2008 922 929
37. J.L. Schnipper, J.L. Kirwin, M.C. Cotugno, and et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization Arch Intern Med 166 2006 565 571
38. P.B. Sandesara, C.T. Lambert, N.F. Gordon, and et al. Cardiac rehabilitation and risk reduction: time to "rebrand and reinvigorate." J Am Coll Cardiol 65 2015 389 395
39. N.D. Shah, S.M. Dunlay, H.H. Ting, and et al. Long-term medication adherence after myocardial infarction: experience of a community Am J Med 122 2009 961.e7 961.e13
40. A. Gehi, D. Haas, S. Pipkin, and et al. Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study Arch Intern Med 165 2005 2508 2513
41. M.A. Brookhart, A.R. Patrick, S. Schneeweiss, and et al. Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use Arch Intern Med 167 2007 847 852
42. D.S. Wald, J.P. Bestwick, L. Raiman, and et al. Randomised trial of text messaging on adherence to cardiovascular preventive treatment (INTERACT trial) PLoS One 9 2014 e114268
43. P.M. Ho, A. Lambert-Kerzner, E.P. Carey, and et al. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial JAMA Intern Med 174 2014 186 193
44. S.F. Derose, K. Green, E. Marrett, and et al. Automated outreach to increase primary adherence to cholesterol-lowering medications JAMA Intern Med 173 2013 38 43
45. H.V. Ganga, H.B. Slim, and P.D. Thompson A systematic review of statin-induced muscle problems in clinical trials Am Heart J 168 2014 6 15
46. H. Zhang, J. Plutzky, S. Skentzos, and et al. Discontinuation of statins in routine care settings: a cohort study Ann Intern Med 158 2013 526 534
47. D. Preiss, S.R. Seshasai, P. Welsh, and et al. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis JAMA 305 2011 2556 2564
48. N.K. Choudhry, J. Avorn, R.J. Glynn, et al. for the Post-Myocardial Infarction Free Rx Event and Economic Evaluation (MI FREEE) Trial Full coverage for preventive medications after myocardial infarction N Engl J Med 365 2011 2088 2097
49. S. Thom, N. Poulter, J. Field, et al. for the UMPIRE Collaborative Group Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial JAMA 310 2013 918 929
50. J.M. Castellano, G. Sanz, J.L. Peñalvo, and et al. A polypill strategy to improve adherence: results from the FOCUS project J Am Coll Cardiol 64 2014 2071 2080
51. P.M. Ho, J.A. Spertus, F.A. Masoudi, and et al. Impact of medication therapy discontinuation on mortality after myocardial infarction Arch Intern Med 166 2006 1842 1847
52. T. Meade, P. Sleight, R. Collins, et al. for the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial Lancet 376 2010 1658 1669
53. T.R. Pedersen, O. Faergeman, J.J. Kastelein, et al. for the Incremental Decrease in End Points Through Aggressive Lipid Lowering (IDEAL) Study Group High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial JAMA 294 2005 2437 2445
54. J.C. LaRosa, S.M. Grundy, D.D. Waters, et al. for the Treating to New Targets (TNT) Investigators Intensive lipid lowering with atorvastatin in patients with stable coronary disease N Engl J Med 352 2005 1425 1435
55. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 7 22
56. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels N Engl J Med 339 1998 1349 1357
57. F.M. Sacks, M.A. Pfeffer, L.A. Moye, et al. for the Cholesterol and Recurrent Events Trial Investigators The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels N Engl J Med 335 1996 1001 1009
58. Scandinavian Simvastatin Survival Study Group Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
59. Y. Yang, V. Thumula, P.F. Pace, and et al. Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: a retrospective cohort study Clin Ther 31 2009 2178 2188 discussion 2150-1
60. J.M. Foody, A.T. Joyce, A.E. Rudolph, and et al. Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: a US managed care study Curr Med Res Opin 24 2008 1987 2000
61. X. Ye, C.R. Gross, J. Schommer, and et al. Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study Clin Ther 29 2007 2748 2757